Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Northwest Biotherapeutics (NWBO) Debt Ratio: 2009-2025

Historic Debt Ratio for Northwest Biotherapeutics (NWBO) over the last 15 years, with Sep 2025 value amounting to 0.55.

  • Northwest Biotherapeutics' Debt Ratio fell 45.99% to 0.55 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.55, marking a year-over-year decrease of 45.99%. This contributed to the annual value of 0.82 for FY2024, which is 22.34% down from last year.
  • Latest data reveals that Northwest Biotherapeutics reported Debt Ratio of 0.55 as of Q3 2025, which was down 11.00% from 0.62 recorded in Q2 2025.
  • Northwest Biotherapeutics' 5-year Debt Ratio high stood at 12.00 for Q2 2021, and its period low was 0.55 during Q3 2025.
  • Moreover, its 3-year median value for Debt Ratio was 0.74 (2023), whereas its average is 0.78.
  • As far as peak fluctuations go, Northwest Biotherapeutics' Debt Ratio soared by 737.91% in 2021, and later plummeted by 80.12% in 2023.
  • Over the past 5 years, Northwest Biotherapeutics' Debt Ratio (Quarterly) stood at 3.29 in 2021, then declined by 15.90% to 2.76 in 2022, then slumped by 61.69% to 1.06 in 2023, then decreased by 22.34% to 0.82 in 2024, then slumped by 45.99% to 0.55 in 2025.
  • Its Debt Ratio stands at 0.55 for Q3 2025, versus 0.62 for Q2 2025 and 0.60 for Q1 2025.